REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,228,617 | -6.1% | 182,111 | -28.6% | 0.01% | -15.4% |
| Q1 2023 | $4,501,958 | +207.9% | 254,924 | +201.2% | 0.01% | +160.0% |
| Q3 2022 | $1,462,000 | +39.0% | 84,634 | +40.6% | 0.01% | +66.7% |
| Q2 2022 | $1,052,000 | -71.7% | 60,207 | -72.5% | 0.00% | -72.7% |
| Q1 2022 | $3,715,000 | +41.7% | 218,792 | +126.2% | 0.01% | +83.3% |
| Q4 2021 | $2,621,000 | -16.7% | 96,708 | -8.9% | 0.01% | -14.3% |
| Q3 2021 | $3,146,000 | -47.8% | 106,156 | -32.3% | 0.01% | -50.0% |
| Q2 2021 | $6,028,000 | -46.4% | 156,888 | -57.4% | 0.01% | -51.7% |
| Q1 2021 | $11,249,000 | -10.4% | 368,695 | +12.1% | 0.03% | -19.4% |
| Q4 2020 | $12,549,000 | +754.3% | 328,932 | +415.3% | 0.04% | +620.0% |
| Q3 2020 | $1,469,000 | +360.5% | 63,835 | +397.7% | 0.01% | +150.0% |
| Q2 2020 | $319,000 | -35.3% | 12,827 | -62.6% | 0.00% | +100.0% |
| Q4 2019 | $493,000 | – | 34,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |